COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,031 Articles (22,627 medRxiv, 8,404 bioRxiv)

Most recent first Previous |  Page 459: Articles 4581-4590  | Next

Utilizing Pre-trained Network Medicine Models for Generating Biomarkers, Targets, Re-purposing Drugs, and Personalized Therapeutic Regimes: COVID-19 Applications
Xiong, J.
10.1101/2023.02.21.527754 — Posted: 2023-02-22
Dynamics of Influenza A and SARS-CoV-2 coinfections during the COVID-19 pandemic in India
Ravikumar, S., Tamboli, E., Rahangdale, S., Salsekar, L., Tomar, S. S., Khairnar, K.
10.1101/2023.02.19.23285730 — Posted: 2023-02-22
REAL-WORLD EFFECTIVENESS OF NIRMATRELVIR/RITONAVIR ON COVID-19-ASSOCIATED HOSPITALIZATION PREVENTION: A POPULATION-BASED COHORT STUDY IN THE PROVINCE OF QUEBEC, CANADA
Kabore, J. L., Laffont, B., Diop, M., Tardif, M. R., Turgeon, A. F., Dumaresq, J., Luong, M.-L., Cauchon, M., Chapdelaine, H., Claveau, D., Brosseau, M., Haddad, E., Benigeri, M.
10.1101/2023.02.14.23285860 — Posted: 2023-02-22
Associations between SARS-CoV-2 infection and incidence of new chronic condition diagnoses: a systematic review
Gaudet, L. A., Pillay, J., Saba, S., Zakaria, D., Cheta, N., Gardiner, H., Shaver, L., Middleton, J., Tan, M., Vandermeer, B., Hartling, L.
10.1101/2023.02.21.23286181 — Posted: 2023-02-22
An empirical analysis of lay media coverage on influenza prevention pre- and post-COVID 19: Mask recommendations were previously rare, now ubiquitous.
Prasad, V., Brown, E., Haslam, A.
10.1101/2023.02.14.23285818 — Posted: 2023-02-22
The Equilibrium and Pandemic Waves of COVID-19 in the US
Hu, Z., Hu, X., Xu, T., Zhang, K., Lu, H. H., Zhao, J., Boerwinkle, E., Jin, L., Xiong, M.
10.1101/2023.02.13.23285847 — Posted: 2023-02-21
Longitudinal dynamics of Streptococcus pneumoniae carriage and SARS-CoV-2 infection in households with children.
Miellet, W. R., Mariman, R., Eggink, D., Nicolaie, M. A., van Veldhuizen, J., Pluister, G., Kolodziej, L. M., van Lelyveld, S., Euser, S. M., Sanders, E. A. M., van Houten, M. A., Trzcinski, K.
10.1101/2023.02.20.23286191 — Posted: 2023-02-21
Recognition and Cleavage of Human tRNA Methyltransferase TRMT1 by the SARS-CoV-2 Main Protease
D'Oliviera, A., Dai, X., Mottaghinia, S., Geissler, E. P., Etienne, L., Zhang, Y., Mugridge, J. S.
10.1101/2023.02.20.529306 — Posted: 2023-02-21
A third vaccine dose equalizes the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens
Guibert, N., Trepat, K., Pozzetto, B., Josset, L., Fassier, J.-B., Allatif, O., Saker, K., Brengel-Pesce, K., Walzer, T., Vanhems, P., Trouillet-Assant, S.
10.1101/2023.02.13.23285853 — Posted: 2023-02-21
Efficient Viral Capture and Inactivation from Bioaerosols Using Electrostatic Precipitation.
Preston, H. E., Bayliss, R., Temperton, N. J., Mayora Neto, M., Brewer, J., Parker, A. L.
10.1101/2023.02.19.529105 — Posted: 2023-02-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).